Shift Bioscience

Developing therapies that target aging at the cellular level.
Developing therapies that target aging at the cellular level.

Sector

Life Sciences

Category

AI
Therapeutics

Location

Cambridge, United Kingdom

Initial Investment

2022
Shift Bioscience

Shift Bioscience (Shift) is a Cambridge, UK-based biotechnology company focused on safe cellular reprogramming for rejuvenation. The company leverages a proprietary cellular age clock and an active machine learning approach to discover novel factors for safer cellular rejuvenation without the use of pluripotency-inducing reprogramming genes. Shift aims to enable the development of reprogramming-based therapeutics to prevent and treat age-associated diseases.